• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗α病毒活性的基孔肯雅病毒nsP2解旋酶对映选择性化学探针

Enantioselective Chemical Probe for Chikungunya nsP2 Helicase with Antialphaviral Activity.

作者信息

Muthu Ramalingam Bose, Oh Hans J, Sears John D, Chen Chun-Hsing, Vala Anand, Liu Shubin, Talbot Kacey M, Hossain Mohammed Anwar, Brown Peter J, Houliston Scott, Garcia Perez Julia, Li Fengling, Amare Meareg G, Halfmann Peter, Smith Jessica L, Hirsch Alec J, Arrowsmith Cheryl H, Halabelian Levon, Vargason Ava, Couñago Rafael M, Arnold Jamie J, Cameron Craig E, Moorman Nathaniel J, Heise Mark T, Willson Timothy M

机构信息

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

READDI AViDD Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

出版信息

ACS Infect Dis. 2025 Aug 8;11(8):2331-2341. doi: 10.1021/acsinfecdis.5c00351. Epub 2025 Jul 18.

DOI:10.1021/acsinfecdis.5c00351
PMID:40680191
Abstract

Chikungunya virus (CHIKV) replication relies on the multifunctional nsP2 protein, making it an attractive target for antiviral drug discovery. Here, we report the resolution of oxaspiropiperidine , a first-in-class inhibitor of the CHIKV nsP2 RNA helicase (nsP2hel), into its constitutive enantiomers and characterization of their antiviral activity. The enantiomer ()- exhibited potent inhibition of viral replication, nsP2hel ATPase activity, and dsRNA unwinding, while the ()- enantiomer was >100-fold less active. The ()- enantiomer also demonstrated a high selectivity for CHIKV over other RNA viruses and for nsP2hel over other RNA helicases. Direct binding of ()- to the nsP2hel protein was confirmed by F NMR. Biophysical and structural studies revealed conformational polymorphism in the spirocyclic scaffold of ()-, suggesting a potential role of thermal mobility of the ligand in allosteric inhibition of nsP2hel. Collectively, these findings designate ()- (RA-NSP2-) as a high-quality chemical probe and ()- (RA-NSP2-N) as a negative control for probing the biology of alphavirus RNA helicases.

摘要

基孔肯雅病毒(CHIKV)的复制依赖于多功能非结构蛋白2(nsP2),这使其成为抗病毒药物研发的一个有吸引力的靶点。在此,我们报告了氧杂螺哌啶(一种CHIKV nsP2 RNA解旋酶(nsP2hel)的一流抑制剂)拆分为其组成对映体的过程及其抗病毒活性的表征。对映体()-表现出对病毒复制、nsP2hel ATP酶活性和双链RNA解旋的有效抑制,而()-对映体的活性则低100倍以上。()-对映体还显示出对CHIKV相对于其他RNA病毒以及对nsP2hel相对于其他RNA解旋酶具有高选择性。通过F NMR证实了()-与nsP2hel蛋白的直接结合。生物物理和结构研究揭示了()-的螺环支架中的构象多态性,表明配体的热运动性在nsP2hel变构抑制中的潜在作用。总体而言,这些发现将()-(RA-NSP2-)指定为用于探究甲病毒RNA解旋酶生物学的高质量化学探针,而将()-(RA-NSP2-N)指定为阴性对照。

相似文献

1
Enantioselective Chemical Probe for Chikungunya nsP2 Helicase with Antialphaviral Activity.具有抗α病毒活性的基孔肯雅病毒nsP2解旋酶对映选择性化学探针
ACS Infect Dis. 2025 Aug 8;11(8):2331-2341. doi: 10.1021/acsinfecdis.5c00351. Epub 2025 Jul 18.
2
Identification of Direct-Acting nsP2 Helicase Inhibitors with Antialphaviral Activity.具有抗α病毒活性的直接作用的nsP2解旋酶抑制剂的鉴定
J Med Chem. 2025 Jul 24;68(14):14514-14536. doi: 10.1021/acs.jmedchem.5c00635. Epub 2025 Jul 9.
3
Targeting the host protein G3BP1 for the discovery of novel antiviral inhibitors against Chikungunya virus.以宿主蛋白G3BP1为靶点发现抗基孔肯雅病毒的新型抗病毒抑制剂。
Virology. 2025 Jul;608:110551. doi: 10.1016/j.virol.2025.110551. Epub 2025 Apr 22.
4
The SHFV nsp2 and nucleocapsid proteins recruit G3BP1 to sites of viral replication, but stress granules are not induced by the infection.裂谷热病毒非结构蛋白2和核衣壳蛋白将G3BP1招募至病毒复制位点,但感染并未诱导应激颗粒的形成。
J Virol. 2025 Jun 23:e0079425. doi: 10.1128/jvi.00794-25.
5
Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity.基孔肯雅病毒非结构蛋白 2 远隔结构域之间的功能串扰对其 RNA 调节活性起决定性作用。
J Biol Chem. 2014 Feb 28;289(9):5635-53. doi: 10.1074/jbc.M113.503433. Epub 2014 Jan 9.
6
Design and Validation of Novel Chikungunya Virus Protease Inhibitors.新型基孔肯雅病毒蛋白酶抑制剂的设计与验证
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7382-7395. doi: 10.1128/AAC.01421-16. Print 2016 Dec.
7
Antiviral efficacy of hexane extract of Hypericum gaitii Haines against Chikungunya and SARS-CoV-2 viruses: in vitro and in silico approaches.盖氏金丝桃己烷提取物对基孔肯雅病毒和新型冠状病毒2的抗病毒效力:体外和计算机模拟方法
J Ethnopharmacol. 2025 Jul 10;353(Pt A):120270. doi: 10.1016/j.jep.2025.120270.
8
Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya.非结构蛋白 2 蛋白酶抑制剂在基孔肯雅热的小鼠模型中显示出良好的疗效。
Eur J Med Chem. 2024 Nov 15;278:116808. doi: 10.1016/j.ejmech.2024.116808. Epub 2024 Aug 30.
9
Exploiting the chikungunya virus capsid protein: a focused target for antiviral therapeutic development.利用基孔肯雅病毒衣壳蛋白:抗病毒治疗开发的重点靶点。
Arch Virol. 2025 May 27;170(7):141. doi: 10.1007/s00705-025-06325-2.
10
Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.赋予基孔肯雅病毒复制子非细胞毒性表型的突变会损害非结构蛋白2的酶活性。
J Virol. 2015 Mar;89(6):3145-62. doi: 10.1128/JVI.03213-14. Epub 2014 Dec 31.

本文引用的文献

1
Identification of Direct-Acting nsP2 Helicase Inhibitors with Antialphaviral Activity.具有抗α病毒活性的直接作用的nsP2解旋酶抑制剂的鉴定
J Med Chem. 2025 Jul 24;68(14):14514-14536. doi: 10.1021/acs.jmedchem.5c00635. Epub 2025 Jul 9.
2
ATPase activity profiling of three human DExD/H-box RNA helicases.三种人类 DExD/H 盒 RNA 解旋酶的 ATP 酶活性分析
SLAS Discov. 2025 Apr;32:100229. doi: 10.1016/j.slasd.2025.100229. Epub 2025 Apr 5.
3
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti-Alphavirus Therapies.
甲病毒非结构蛋白2:病毒复制的多功能调节因子及抗甲病毒疗法的潜在靶点
Rev Med Virol. 2025 Mar;35(2):e70030. doi: 10.1002/rmv.70030.
4
Structural Chemistry of Helicase Inhibition.解旋酶抑制的结构化学
J Med Chem. 2025 Feb 27;68(4):4022-4039. doi: 10.1021/acs.jmedchem.4c01909. Epub 2025 Feb 11.
5
Regulation and mechanisms of action of RNA helicases.RNA 解旋酶的调控和作用机制。
RNA Biol. 2024 Jan;21(1):24-38. doi: 10.1080/15476286.2024.2415801. Epub 2024 Oct 22.
6
Allosteric drugs: New principles and design approaches.变构药物:新的原理和设计方法。
Curr Opin Struct Biol. 2024 Feb;84:102758. doi: 10.1016/j.sbi.2023.102758. Epub 2024 Jan 2.
7
Cellular functions of eukaryotic RNA helicases and their links to human diseases.真核 RNA 解旋酶的细胞功能及其与人类疾病的关联。
Nat Rev Mol Cell Biol. 2023 Oct;24(10):749-769. doi: 10.1038/s41580-023-00628-5. Epub 2023 Jul 20.
8
Molecular architecture of the Chikungunya virus replication complex.基孔肯雅病毒复制复合体的分子结构
Sci Adv. 2022 Dec 2;8(48):eadd2536. doi: 10.1126/sciadv.add2536. Epub 2022 Nov 30.
9
The life cycle of the alphaviruses: From an antiviral perspective.甲病毒的生命周期:从抗病毒的角度来看。
Antiviral Res. 2023 Jan;209:105476. doi: 10.1016/j.antiviral.2022.105476. Epub 2022 Nov 25.
10
Biological functions of DEAD/DEAH-box RNA helicases in health and disease.DEAD/DEAH -box RNA 解旋酶在健康和疾病中的生物学功能。
Nat Immunol. 2022 Mar;23(3):354-357. doi: 10.1038/s41590-022-01149-7.